SEC Form D private-offering filing

Longeveron Inc.

Name: Longeveron Inc. - new SEC Form D private-offering filing, Miami, FL
Published: 2026-03-25

A new SEC Form D private-offering notice from Miami, FL, a $33,515,000 filer-stated offering target in Biotech. The source filing is one click away.

Longeveron Inc. site↗ Verified via SEC Form D

Clinical-stage biotech developing laromestrocel (Lomecel-B), a stem cell therapy for cardiac, Alzheimer's, and aging-related conditions; Nasdaq-listed as LGVN.

Filed 2026-03-25Filed to raise $33,515,000First money in 2026-03-11Raised so far $15,890,000HQ (as filed) Miami, FLSector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified longeveron.com↗Named in the filing 10 executives & directors

Open this row on the live feed →More new filings in Florida →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.